1.1 Background of the Study
The drug discovery and development process is often characterized by high costs, extensive timelines, and a significant risk of failure. Traditional methods rely on trial-and-error approaches that are resource-intensive and time-consuming. Artificial Intelligence (AI) has emerged as a game-changer in this domain, leveraging machine learning algorithms, molecular modeling, and big data analytics to streamline the identification of drug candidates and their subsequent development. AI tools, such as AlphaFold and Schrödinger's computational platforms, have demonstrated remarkable potential in predicting protein structures, simulating drug interactions, and expediting clinical trials. Recent studies (Chakraborty & Singh, 2024; Ahmad et al., 2025) highlight that AI can reduce drug development costs by up to 50% while increasing the probability of success in clinical trials.
At the Federal Medical Center in Katsina State, the integration of AI into drug discovery offers a unique opportunity to address regional healthcare challenges, including the prevalence of tropical diseases and limited access to affordable medications. AI-driven systems can identify novel compounds, repurpose existing drugs, and optimize treatment protocols for local populations. However, challenges such as data scarcity, infrastructural constraints, and regulatory barriers persist, hindering the full potential of AI in this critical area. This study investigates the transformative role of AI in drug discovery at Federal Medical Center, Katsina State, with a focus on its impact, challenges, and strategic opportunities.
1.2 Statement of the Problem
Drug development in Nigeria is hindered by limited research infrastructure, high costs, and a lack of advanced technological tools. These challenges contribute to the slow pace of innovation in addressing endemic diseases, such as malaria and tuberculosis. While AI offers promising solutions to accelerate drug discovery and optimize therapeutic outcomes, its adoption in resource-constrained environments like Katsina State remains limited. This research aims to evaluate the role of AI in overcoming these barriers, providing actionable insights for its integration into drug discovery processes at the Federal Medical Center.
1.3 Objectives of the Study
1. To assess the impact of AI on drug discovery and development processes at Federal Medical Center, Katsina State.
2. To identify the challenges of implementing AI-driven drug discovery tools in resource-constrained environments.
3. To recommend strategies for enhancing the adoption of AI in drug discovery and development in Katsina State.
1.4 Research Questions
1. What is the impact of AI on drug discovery and development at Federal Medical Center, Katsina State?
2. What challenges affect the implementation of AI-driven drug discovery tools in Katsina State?
3. What strategies can enhance the adoption and effectiveness of AI in drug discovery and development?
1.5 Research Hypothesis
1. AI significantly accelerates the drug discovery and development process at Federal Medical Center, Katsina State.
2. Resource limitations and regulatory barriers are major challenges to AI implementation in drug discovery.
3. Strategic interventions and investments can improve the adoption of AI in drug development processes.
1.6 Significance of the Study
This study holds relevance for healthcare researchers, policymakers, and pharmaceutical companies. It provides evidence of AI's transformative impact on drug discovery and development, particularly in addressing diseases prevalent in Katsina State. Policymakers can use the findings to formulate strategies that promote AI adoption and regulatory frameworks. Pharmaceutical companies may gain insights into the operational and financial benefits of AI-driven drug discovery, fostering innovation in affordable drug development.
1.7 Scope and Limitations of the Study
The study focuses on the role of AI in drug discovery and development at the Federal Medical Center in Katsina State. It examines processes such as drug candidate identification, molecular modeling, and clinical trials. Data collection involves stakeholder interviews, reviews of AI tools, and analysis of ongoing drug discovery projects. Limitations include restricted access to proprietary data, financial constraints in implementing AI systems, and the region-specific nature of the findings, which may not generalize to other healthcare settings.
1.8 Operational Definition of Terms
1. Drug Discovery: The process of identifying new therapeutic compounds for the treatment of diseases.
2. Molecular Modeling: Computational techniques used to predict the structure and interactions of molecules in drug development.
3. Clinical Trials: Research studies that test the safety and efficacy of new drugs or treatments on human participants.
4. Tropical Diseases: Diseases prevalent in tropical regions, such as malaria and dengue, often associated with resource-constrained healthcare systems.
5. Big Data Analytics: The use of advanced analytical techniques to process and interpret large datasets for decision-making.
ABSTRACT
The study investigated the effects of 5E-Learning Model on Creativity, Performance and Retention in Ecology among Secondary Scho...
STATEMENT OF RESEARCH PROBLEM
The hospitality in...
THE ROLE OF CUSTOMER RELATIONSHIP MANAGEMENT (CRM) SYSTEMS IN SALES EFFECTIVENESS
This...
ABSTRACT
This study was carried out on the effect of the Twitter ban on small businesses in Niger...
ABSTRACT
The study was carried out to examine the effects of electronic instructional medium on seconda...
ABSTRACT: The role of early childhood education in social-emotional learni...
ABSTRACT
With the achievement of puberty, the adolescent becomes sexually active and competent. This maturity invo...
Abstract: ASSESSMENT OF TAX PLANNING STRATEGIES FOR HIGH-NET-WORTH INDIVIDUALS
This research examines tax planning strategies for high-ne...
Statement of the Problem
In spite of the rapid growth of Lagos in recent times, road transport remains the main means of transportation i...
Chapter One: Introduction
Background of the Study
Standard costing is a widely recognized cost accounting technique that involv...